Drugs in pregnancy--the issues for 2010.
A Motherisk symposium on establishing benchmarks for the evaluation of medications during pregnancy, was held on May 10, 2006, under the auspices of the Canadian Society of Pharmacology and Therapeutics. From that symposium came a consensus on the need for collection and analysis of data on fetal safety and ongoing post-marketing surveillance, which in turn led to the establishment of CaseMed-Pregnancy--the Canadian Alliance for Safe and Effective Medication During Pregnancy and Breastfeeding.
Donald B
DB
Davis
D002170:Canada; D003625:Data Collection; D004348:Drug Labeling; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D007774:Lactation; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011358:Product Surveillance, Postmarketing / Q000379:methods; D012952:Societies
D004364:Pharmaceutical Preparations